首页> 外文期刊>Nature reviews. Urology >Prostate cancer: HIFU is effective, but associated morbidity still remains unclear.
【24h】

Prostate cancer: HIFU is effective, but associated morbidity still remains unclear.

机译:前列腺癌:HIFU有效,但相关的发病率仍不清楚。

获取原文
获取原文并翻译 | 示例
           

摘要

The average age of men diagnosed with prostate cancer is falling, and thus the burden of morbidity associated with its treatment is of great interest. Physicians want to provide their patients with definitive cancer treatment, but without the morbidity which is associated with surgery and radiotherapy. Ablative therapy, using modalities such as high-frequency focused ultrasound (HIFU), offers an exciting prospect for in situ definitive treatment of prostate cancer, with a theoretical reduction in associated adverse effects.
机译:被诊断出患有前列腺癌的男性的平均年龄正在下降,因此与其治疗相关的发病率负担引起了极大的兴趣。医师希望为患者提供确定的癌症治疗,但不给与手术和放疗相关的发病率。使用高频聚焦超声(HIFU)等方式进行的消融治疗为前列腺癌的原位明确治疗提供了令人兴奋的前景,并在理论上减少了相关的不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号